IBM and Boehringer Ingelheim's partnership aim to accelerate the antibody discovery process to treat diseases like cancer, through in-silico processes.
ERP Today has established itself as THE independent voice of the enterprise technology sector through its use of dynamic journalism, creativity and purpose.
Subscribe





























